The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness


Baser O., Waters H. C., Yapar N., Samayoa G., Han X., Freedman D., ...Daha Fazla

American Journal of Managed Care, cilt.32, sa.6, 2026 (SCI-Expanded, SSCI, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 32 Sayı: 6
  • Basım Tarihi: 2026
  • Doi Numarası: 10.37765/ajmc.2026.89961
  • Dergi Adı: American Journal of Managed Care
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Social Sciences Citation Index (SSCI), Scopus, ABI/INFORM, CINAHL, EMBASE, MEDLINE, Academic Search Ultimate (EBSCO), Biomedical Reference Collection: Corporate Edition (EBSCO), Health Research Premium Collection (ProQuest)
  • Boğaziçi Üniversitesi Adresli: Evet

Özet

OBJECTIVE: Health care resource utilization (HCRU) and cost among Medicaid patients with serious mental illness (SMI) were compared in states with high and low reimbursement for psychiatric services. STUDY DESIGN: Retrospective cohort study. METHODS: Using 2021-2023 Kythera Labs Medicaid data, the 20 most frequently billed procedures by psychiatrists were identified. We selected states with the top 20% and bottom 20% mean reimbursement. The SMI population had 1 or more medical claims for SMI during the identification period and continuous enrollment for 1 year pre-and post diagnosis. The effect of reimbursement rates on health outcomes was estimated, controlling for patient-level and fixed-state characteristics. RESULTS: The high-reimbursement-rate cohort (n = 99,024) was 5% less likely to have psychiatric-specific inpatient and outpatient visits and 23% less likely to have psychiatric-specific emergency department (ED) visits than the low-reimbursement cohort (n = 154,437). The high-reimbursement cohort was less likely to have inpatient and ED visits and demonstrated 24% lower overall costs and 19% lower psychiatric-specific costs annually. CONCLUSIONS: Higher Medicaid reimbursement rates for psychiatric services were associated with reduced HCRU and costs. Although this observed association may not imply causality, it could reflect beneficial behavioral changes (eg, improved provider participation and care continuity) or unintended mechanisms such as increased utilization review that may restrict access.